Search | TVST | ARVO Journals

Showing 1 – 20 of 87

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

The Repeatability of Tests for Dry Eye Signs in the Dry Eye Assessment and Management (DREAM) Study

Anna Chen; Patrick Augello; Penny A Asbell; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2935.

ARVO Annual Meeting Abstract June 2024

Prevalence and Risk factors for the Development of Persistent Postoperative Pain after Cataract Surgery in the Age-Related Eye Disease Study (AREDS)

Rony R Sayegh; Susan Vitale; Elvira Agron; John T Farrar; Penny A Asbell; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2642.

ARVO Annual Meeting Abstract June 2024

Inter-eye agreement in dry eye signs in the Dry Eye Assessment and Management (DREAM) Study – Implications for design and statistical analysis of dry eye trials

Anny Zhong; Patrick Augello; Penny A Asbell; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2948.

ARVO Annual Meeting Abstract June 2024

Association between lid margin collarettes and dry eye disease in the Dry Eye Assessment and Management (DREAM) study

Alexander E Azar; Eliot N Haddad; Penny A Asbell; Gui-Shuang Ying; Rony R Sayegh

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2934.

ARVO Annual Meeting Abstract June 2024

Longitudinal Analysis of Tear Cytokine Ratios in Association with Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study

Cindy Siyang Zhao; Yineng Chen; Gui-Shuang Ying; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):415.

ARVO Annual Meeting Abstract June 2024

Magnitude and Predictors of Placebo Effects in Dry Eye Assessment and Management (DREAM) Study

Katherine Han; Yinxi Yu; Penny A Asbell; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):410.

ARVO Annual Meeting Abstract June 2024

Association of severity of dry eye symptoms and signs with the quality of life in the Dry Eye Assessment and Management (DREAM) Study

Qianqian Ellie Cheng; Yineng Chen; Katherine Han; Penny A Asbell; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2947.

ARVO Annual Meeting Abstract June 2024

Meibomian Gland Dysfunction (MGD) in the Dry Eye Assessment and Management (DREAM©) study

Divya Jagadeesh; Meng C Lin; Jocelyn He; Gui-Shuang Ying; Fiona Stapleton; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6563.

ARVO Annual Meeting Abstract June 2024

A novel ocular formulation of pimecrolimus for treatment of dry eye

Penny A Asbell; Ian Vessey

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2956.

ARVO Annual Meeting Abstract June 2024

Making ocular biomarkers count: Validity and standardization for tear fluid

Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6196.

Cornea September 2023

Association of Ocular Surface Immune Cells With Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study

PDF

Eric J. Kuklinski; Yinxi Yu; Gui-Shuang Ying; Penny A. Asbell; for the DREAM Study Research Group
TAGS: dreams, dry eye syndromes, ocular surfaces, signs and symptoms, eye
Invest. Ophthalmol. Vis. Sci.. 2023; 64(12):7. https://doi.org/10.1167/iovs.64.12.7

ARVO Annual Meeting Abstract June 2023

Longitudinal Analysis of In Vitro Antibiotic Resistance Rates among Ocular Staphylococci Collected in the ARMOR Study

Penny A Asbell; Christine M Sanfilippo; Heleen DeCory

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):591.

ARVO Annual Meeting Abstract June 2023

Association Between Systemic Medication Use and Severity of Dry Eye Symptoms and Signs in the DREAM Study

Michelle Guo; Chandani Patel; Yinxi Yu; John Farrar; Penny A Asbell; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2877.

ARVO Annual Meeting Abstract June 2023

Association of Ocular Surface Immune Cells with Dry Eye Signs and Symptoms at Baseline in the Dry Eye Assessment and Management (DREAM) Study

Eric Kuklinski; Yinxi Yu; Gui-Shuang Ying; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3965.

ARVO Annual Meeting Abstract June 2023

Two-Year Progression of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study

Daniel Lee; Yinxi Yu; Vatinee Y Bunya; Penny A Asbell; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3964.

ARVO Annual Meeting Abstract June 2023

Evaluation of systemic immune markers in dry eye disease and a comparison of subjects with and without Sjogren’s syndrome in the Dry Eye Assessment and Management (DREAM © ) Study

Marium Hashemi; Gui-Shuang Ying; Di Zhu; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3943.

ARVO Annual Meeting Abstract June 2023

Antibiotic Resistance Among Ocular Pathogens – An Update from the 2022 ARMOR Study

Christine M Sanfilippo; Heleen DeCory; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5186.

ARVO Annual Meeting Abstract June 2023

A Latent Profile Analysis of Tear Cytokine Levels for Their Association with Severity of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study

Yineng Chen; Penny A Asbell; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):674.

Cornea January 2023

Association of Tear Osmolarity With Signs and Symptoms of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study

PDF

Jack V. Greiner; Gui-shuang Ying; Maxwell Pistilli; Maureen G. Maguire; Penny A. Asbell; for the Dry Eye Assessment and Management (DREAM) Study Research Group
TAGS: dreams, dry eye syndromes, osmolar concentration, signs and symptoms
Invest. Ophthalmol. Vis. Sci.. 2023; 64(1):5. https://doi.org/10.1167/iovs.64.1.5

Includes: Supplemental Content

Cornea & External Disease November 2022

Dry Eye Subtypes in the Dry Eye Assessment and Management (DREAM) Study: A Latent Profile Analysis

PDF

Kimberley Yu; Penny A. Asbell; Roni M. Shtein; Gui-Shuang Ying; for Dry Eye Assessment and Management Study Research Group
TAGS: dreams, dry eye syndromes, signs and symptoms, omega-3 fatty acids
Trans. Vis. Sci. Tech.. 2022; 11(11):13. https://doi.org/10.1167/tvst.11.11.13

Includes: Supplemental Content

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

The Repeatability of Tests for Dry Eye Signs in the Dry Eye Assessment and Management (DREAM) Study

Prevalence and Risk factors for the Development of Persistent Postoperative Pain after Cataract Surgery in the Age-Related Eye Disease Study (AREDS)

Inter-eye agreement in dry eye signs in the Dry Eye Assessment and Management (DREAM) Study – Implications for design and statistical analysis of dry eye trials

Association between lid margin collarettes and dry eye disease in the Dry Eye Assessment and Management (DREAM) study

Longitudinal Analysis of Tear Cytokine Ratios in Association with Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study

Magnitude and Predictors of Placebo Effects in Dry Eye Assessment and Management (DREAM) Study

Association of severity of dry eye symptoms and signs with the quality of life in the Dry Eye Assessment and Management (DREAM) Study

Meibomian Gland Dysfunction (MGD) in the Dry Eye Assessment and Management (DREAM©) study

A novel ocular formulation of pimecrolimus for treatment of dry eye

Making ocular biomarkers count: Validity and standardization for tear fluid

Association of Ocular Surface Immune Cells With Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study

Longitudinal Analysis of In Vitro Antibiotic Resistance Rates among Ocular Staphylococci Collected in the ARMOR Study

Association Between Systemic Medication Use and Severity of Dry Eye Symptoms and Signs in the DREAM Study

Association of Ocular Surface Immune Cells with Dry Eye Signs and Symptoms at Baseline in the Dry Eye Assessment and Management (DREAM) Study

Two-Year Progression of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study

Evaluation of systemic immune markers in dry eye disease and a comparison of subjects with and without Sjogren’s syndrome in the Dry Eye Assessment and Management (DREAM © ) Study

Antibiotic Resistance Among Ocular Pathogens – An Update from the 2022 ARMOR Study

A Latent Profile Analysis of Tear Cytokine Levels for Their Association with Severity of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study

Association of Tear Osmolarity With Signs and Symptoms of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study

Dry Eye Subtypes in the Dry Eye Assessment and Management (DREAM) Study: A Latent Profile Analysis

To View More...

You must be signed into an individual account to use this feature.